ロード中...
Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction
Oral phosphodiesterase type 5 (PDE5) inhibitors have provided non-invasive, effective, and well-tolerated treatments for patients with erectile dysfunction (ED). However, many patients with ED are unresponsive to 'on-demand' PDE5 inhibitors. In addition, the lack of spontaneity and natural...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Urological Association
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382685/ https://ncbi.nlm.nih.gov/pubmed/22741044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2012.53.6.377 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|